Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
Recent Patents on Inflammation & Allergy Drug Discovery|June 9, 2018
Evaluation of the Effect of α-L-Guluronic Acid (G2013) on COX-1, COX-2 Activity and Gene Expression for Introducing this Drug as a Novel NSAID with Immunomodulatory PropertyAbbas Mirshafiey, Seyed S Mortazavi-Jahromi, Mahsa Taeb, et al.
Arthritis|November 8, 2012
The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritisMaryam Gol-Ara, Farhad Jadidi-Niaragh, Reza Sadria, et al.
Immunopharmacology and Immunotoxicology|March 18, 2010
Therapeutic effect of EDTA in experimental model of multiple sclerosisG Mosayebi, D Haghmorad, S Namaki, et al.
Avicenna Journal of Medical Biotechnology|February 15, 2013
Intermittent feeding attenuates clinical course of experimental autoimmune encephalomyelitis in C57BL/6 miceLaya Kafami, Mohsin Raza, Alireza Razavi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 2, 2017
An in vitro evaluation of anti-aging effect of guluronic acid (G2013) based on enzymatic oxidative stress gene expression using healthy individuals PBMCsMahsa Taeb, Seyed Shahabeddin Mortazavi-Jahromi, Abdollah Jafarzadeh, et al.
Future Virology|August 19, 2022
Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation studyFatemeh Sana Askari, Mohsen Ebrahimi, Jabbar Parhiz, et al.
Immunologic Research|November 27, 2018
Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory propertiesSeyed Shahabeddin Mortazavi-Jahromi, Sepideh Nazeri, Fahimeh Jafarnezhad-Ansariha, et al.
International Immunopharmacology|January 9, 2018
Effects of guluronic acid (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathwaySeyed Shahabeddin Mortazavi-Jahromi, Ali Farazmand, Nasrin Motamed, et al.
Pageof 20